AgricultureNutritionNutritional SciencesContraceptionLactationMilk QualityHuman LactationHuman Milk CompositionLactation EndocrinologyLactation NutritionMilk ProductionMilk SecretionControl Group DesignEndocrine HormonesHormonal Contraception During LactationHuman Milk SecretionMaternal Milk SupplyMilk Carbohydrate SecretionMilk Fat SecretionMilk Lactose Content
The oral contraceptives primovlar minovlar and norgestrel were administered on the basis of the endocrine profile to 94 lactating women and were compared with a control group of 42. After an initial assessment at 6 weeks postpartum oral contraceptive therapy was begun and a further assessment was made at 10 14 and 18 weeks. Quantity was measured by the weight of the infant at feeding and the expression of remaining milk by pump. Quality of expressed milk was determined by studies for fat protein albumin globulin and lactose content. The 3 assessments showed a diminution in quantity of 13% 18% and 28% in the control group 13% 20% and 30% in norgestrel whereas the primovlar and minovlar groups showed a reduction of 25% (p less than .05) 39% (p less than .01) 57% (p less than .01) and of 18% 38% (p less than .01) and 54% (p less than .01) respectively. Supplementary feedings of more than 4 were required in 7% of norgestrel and control groups but in 26% and 30% of the primovlar and minovlar groups respectively. All parameters of quality showed no significant change. These results indicate that estrogens inhibit milk secretion. The number of dropouts due to side effects with primovlar was 10.5% with minovlar 11.7% but with norgestrel 30.2%. These rates are less than those reported in the literature indicating that selection of oral contraceptives on the basis of an endocrine profile reduces the number of dropouts.